Oncología radioterápica
Servicio
Wellcome Trust Sanger Institute
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de Wellcome Trust Sanger Institute (8)
2023
-
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
Radiotherapy and Oncology, Vol. 187
-
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
JNCI Cancer Spectrum, Vol. 7, Núm. 6
2022
-
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity
International Journal of Radiation Oncology Biology Physics, Vol. 114, Núm. 3, pp. 494-501
-
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
eBioMedicine, Vol. 84
2021
-
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
Radiotherapy and Oncology, Vol. 159, pp. 241-248
2019
2018
-
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Nature Communications, Vol. 9, Núm. 1
-
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications, Vol. 9, Núm. 1